Carbapenemase Differentiation Disk Plus
A system that quickly detects the intrusion of microorganisms and implements infection control measures.
In recent years, carbapenem-resistant Enterobacteriaceae (CRE) have been spreading globally. CRE are resistant to all β-lactam antibiotics. The Ministry of Health, Labour and Welfare stipulates that when a patient is diagnosed with a CRE infection, a report must be submitted within seven days according to the provisions of Article 12, Paragraph 1 of the law. However, since the MIC values of meropenem can also increase in AmpC-producing and outer membrane permeable mutant strains, it is considered important to differentiate between these. The need for a system to quickly detect the invasion of such armed microorganisms and implement infection control measures is becoming increasingly urgent, and we have prepared the "Carbapenemase Differentiation Disk Plus."
- Company：関東化学株式会社 バイオケミカル部
- Price：Other
